Abstract
Background Quarantine of healthcare workers (HCWs) exposed to COVID -19 confirmed cases is a well-known strategy for limiting the transmission of infection. However, there is need of evidence-based guidelines for quarantine of HCWs in COVID -19.
Methods We describe our experience of contact tracing and risk stratification of 3853 HCWs who were exposed to confirmed COVID-19 cases in a tertiary health care institution in India. We developed an algorithm, on the basis of risk stratification, to rationalize quarantine among HCWs. Risk stratification was based on the duration of exposure, distance from the patient, and appropriateness of personal protection equipment (PPE) usage. Only high-risk contacts were quarantined for 14 days. They underwent testing for COVID-19 after five days of exposure, while low-risk contacts continued their work with adherence to physical distancing, hand hygiene, and appropriate use of PPE. The low-risk contacts were encouraged to monitor for symptoms and report for COVID-19 screening if fever, cough, or shortness of breath occurred. We followed up all contacts for 14 days from the last exposure and observed for symptoms of COVID-19 and test positivity.
Results and interpretation Out of total 3853 contacts, 560 (14.5%) were categorized as high-risk contacts, and 40 of them were detected positive for COVID-19, with a test positivity rate of 7.1% (95% CI = 5.2 – 9.6). Overall, 118 (3.1%) of all contacts tested positive. Our strategy prevented 3215 HCWs from being quarantined and saved 45,010 person-days of health workforce until June 8, 2020, in the institution.
We conclude that exposure-based risk stratification and quarantine of HCWs is a viable strategy to prevent unnecessary quarantine, in a healthcare institution.
What is already known about this subject?
Quarantine of HCWs is a well-known strategy for community and HCWs to prevent the transmission of COVID-19.
Though success stories of prompt contact tracing and quarantine to control COVID-19 are available from countries like South Korea, Singapore, and Hong Kong, there is a scarcity of evidence that could guide targeted quarantine of HCWs exposed to COVID -19 in India.
What does this study add?
Only 14.5% HCWs exposed to COVID-19 cases were stratified “high risk” contacts, and the most common reason for high-risk contacts was non-formal workplace interactions such as having meals together.
The overall test positivity rate among the high-risk contacts was 7.1%, while it was higher in symptomatic high-risk contacts as compared to those who were asymptomatic (10.2% vs. 6.3%).
How might this impact on clinical practice?
Contact tracing and risk stratification can be used to minimize unnecessary quarantine of COVID-19 exposed health care workers and prevent the depletion of healthcare workers amidst the pandemic to continue the healthcare services optimally.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Although, this study was not funded, the tests of contacts were conducted in the virology laboratory at AIIMS, New Delhi. The virology laboratory at AIIMS is a Department of Health Research (DHR)/ Indian Council of Medical Research (ICMR) funded Regional Viral Research and Diagnostic Laboratory (R-VRDL).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Institute Ethics Committee, AIIMS, New Delhi
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Email: ravneetk08{at}gmail.com
Email: skant76{at}gmail.com
Email: drmohanbairwa{at}gmail.com
Email: linktoarvind{at}gmail.com
Email: dhakad.shivramaiims{at}gmail.com
Email: d.vignesh1991{at}gmail.com
Email: aftab.ind{at}gmail.com
Email: pooja_kmc20{at}yahoo.co.in
Email: akapilmicro{at}aiims.edu
Email: rakesh_lodha{at}hotmail.com
Email: naveetwig{at}gmail.com
Data Availability
Data are available on request. Deidentified data will be made available on request from a bona fide research institute or entity for use in a valid research study. Requests should be made via email to Ravneet Kaur (ravneetk08{at}gmail.com).